Multiple Sclerosis
‘Readily available’ biomarkers may predict cancer survivors at risk for cardiomyopathy
The combination of abnormal baseline global longitudinal strain and N-terminal-pro-B-type natriuretic peptide is associated with a more than fourfold risk for subsequent cardiomyopathy among certain childhood cancer survivors.
Better sleep linked to improved verbal memory in multiple sclerosis
WEST PALM BEACH, Fla. — In two separate cohorts of individuals with multiple sclerosis and memory issues, better sleep was linked to improved verbal memory, according to a poster at ACTRIMS 2024.
Study: Kidney disease-related cognitive impairment may improve after transplantation
Kidney disease-related cognitive impairment, such as episodic and verbal declarative memory, may improve after transplantation, researchers found in a longitudinal study.
Survival data show ‘immense burden’ of ESKD on mortality
Compared with illnesses like cancer, heart failure and dementia, patients with end-stage kidney disease alone have among the lowest rates of survival after 5 years, Stanford University researchers reported in a published study.
Study: Youths risk major adverse kidney event after continuous kidney replacement therapy
Major adverse kidney events occurred in a large portion of youths 90 days after undergoing continuous kidney replacement therapy, according to a published cohort study.
Relapses reduced by 67% after 72 months with ozanimod in patients with multiple sclerosis
WEST PALM BEACH, Fla. — In an open-label extension, treatment with ozanimod demonstrated sustained efficacy for disease progression in patients with relapsing multiple sclerosis, per research presented at ACTRIMS 2024.
COVID-19 caused ‘substantial deficit’ of cancer diagnoses in first 10 months of pandemic
More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.
Women may experience greater mortality gains with physical activity than men
Compared with men, women are less likely to die of any cause or from CV-specific causes when performing similar amounts of weekly leisure-time physical activity, suggesting there are sex-specific benefits to exercise, researchers reported.
Biopharma firm raises $30M to advance neuro, derm tyrosine kinase 2 inhibitors
An Indianapolis-area biopharmaceutical company announced it has raised $30 million in Series B financing to advance investigational tyrosine kinase 2 inhibitors for multiple sclerosis as well as dermatologic conditions.
Being physically active before pandemic reduced odds of having COVID-19
Higher physical activity levels before the COVID-19 pandemic were associated with lower odds of developing and being hospitalized for COVID-19 in older adults, according to a recent study.